Philip D. Leming
- Oncology top 2%
- Immunology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Cancer Research top 10%
- Co-authors
- David C. SmithJohn D. PowderlyJohn M. KirkwoodF. Stephen HodiScott AntoniaJulie R. BrahmerScott GettingerDavid R. Spigel
- Topics
- Cancer Immunotherapy and Biomarkers (9 papers)CAR-T cell therapy research (5 papers)Immunotherapy and Immune Responses (3 papers)
- Journals
- JAMAJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesGermany
In The Last Decade
Philip D. Leming
21 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Oncology 1.5k
- Immunology 608
- Pulmonary and Respiratory Medicine 580
- Molecular Biology 471
- Cancer Research 177
Countries citing papers authored by Philip D. Leming
This map shows the geographic impact of Philip D. Leming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip D. Leming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip D. Leming more than expected).
Fields of papers citing papers by Philip D. Leming
This network shows the impact of papers produced by Philip D. Leming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip D. Leming. The network helps show where Philip D. Leming may publish in the future.
Co-authorship network of co-authors of Philip D. Leming
This figure shows the co-authorship network connecting the top 25 collaborators of Philip D. Leming. A scholar is included among the top collaborators of Philip D. Leming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip D. Leming. Philip D. Leming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumabbreakdown → | 409 |
| 2 | Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: Results From the CA209-003 Studybreakdown → | 539 |
| 3 | 41 | |
| 4 | 1 | |
| 5 | 273 | |
| 6 | 100 | |
| 7 | 15 | |
| 8 | 6 | |
| 9 | 65 | |
| 10 | 90 | |
| 11 | 20 | |
| 12 | 160 | |
| 13 | 1 | |
| 14 | 2 | |
| 15 | 45 | |
| 16 | 34 | |
| 17 | 4 | |
| 18 | 1 | |
| 19 | 21 | |
| 20 | 8 |
About Philip D. Leming
Philip D. Leming is a scholar working on Toxicology, Internal Medicine and Oncology, having authored 21 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (5 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Oncology (1.5k citations), Immunology (608 citations) and Pulmonary and Respiratory Medicine (580 citations). Philip D. Leming has collaborated with scholars based in United States and Germany. Frequent co-authors include David C. Smith, John D. Powderly, John M. Kirkwood, F. Stephen Hodi, Scott Antonia, Julie R. Brahmer, Scott Gettinger, David R. Spigel, David F. McDermott and Leora Horn. Their work appears in journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.